title: Acute kidney injury in critically ill cirrhotic patients: a review.
abstract: Acute kidney injury (AKI) is an important marker of morbidity and mortality in critically ill cirrhotic patients. The most common causes of AKI in cirrhotic patients include prerenal or hepatorenal syndrome (HRS). Diagnosis of AKI may be delayed by the lack of clinical, biochemical, and radiological markers with proven sensitivity and specificity in cirrhotic patients. In this review, we discuss the epidemiology, pathophysiology, diagnosis, and therapies for AKI in cirrhotic patients admitted to an intensive care unit (ICU).
authors.affiliation: Intensive Care Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
authors.forename: Jimena
authors.initials: J
authors.lastname: Muciño-Bermejo
authors.forename: Raúl
authors.initials: R
authors.lastname: Carrillo-Esper
authors.forename: Misael
authors.initials: M
authors.lastname: Uribe
authors.forename: Nahum
authors.initials: N
authors.lastname: Méndez-Sánchez
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis / Q000453:epidemiology* / Q000503:physiopathology*; D015415:Biomarkers / Q000097:blood; D015897:Comorbidity; D016638:Critical Illness / Q000453:epidemiology*; D055316:Cystatin C / Q000097:blood; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging; D008103:Liver Cirrhosis / Q000453:epidemiology* / Q000503:physiopathology; D017582:Renal Replacement Therapy; D014463:Ultrasonography; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D055316:Cystatin C; D014662:Vasoconstrictor Agents